Self-immolative linkers in polymeric delivery systems

There has been significant interest in the methodologies of controlled release for a diverse range of applications spanning drug delivery, biological and chemical sensors, and diagnostics. The advancement in novel substrate-polymer coupling moieties has led to the discovery of self-immolative linkers. This new class of linker has gained popularity in recent years in polymeric release technology as a result of stable bond formation between protecting and leaving groups, which becomes labile upon activation, leading to the rapid disassembly of the parent polymer. This ability has prompted numerous studies into the design and development of self-immolative linkers and the kinetics surrounding their disassembly. This review details the main concepts that underpin self-immolative linker technologies that feature in polymeric or dendritic conjugate systems and outlines the chemistries of amplified self-immolative elimination.

[1]  G. Schreiber,et al.  Poly(ethylene glycol)-doxorubicin conjugates containing beta-lactamase-sensitive linkers. , 1995, Bioconjugate chemistry.

[2]  Martha Anderson,et al.  Novel immunoconjugates comprised of streptonigrin and 17-amino-geldanamycin attached via a dipeptide-p-aminobenzyl-amine linker system. , 2009, Bioorganic & medicinal chemistry letters.

[3]  D. McGrath,et al.  Phototriggering of geometric dendrimer disassembly: An improved synthesis of 2,4-bis(hydroxymethyl)phenol based dendrimers , 2004 .

[4]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.

[5]  A. Wahl,et al.  Protease-mediated fragmentation of p-amidobenzyl ethers: a new strategy for the activation of anticancer prodrugs. , 2002, The Journal of organic chemistry.

[6]  D. Filpula,et al.  Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins. , 2006, Bioconjugate chemistry.

[7]  Phil S Baran,et al.  Activity-linked labeling of enzymes by self-immolative polymers. , 2009, Bioconjugate chemistry.

[8]  Dendritic chain reaction: responsive release of hydrogen peroxide upon generation and enzymatic oxidation of methanol. , 2010, Bioorganic & medicinal chemistry.

[9]  Zheng-Rong Lu,et al.  Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[10]  ADRIEN ALBERT,et al.  Chemical Aspects of Selective Toxicity , 1958, Nature.

[11]  A New Synthesis of Carmethizole and Related Nitrogen Analogues. , 1997 .

[12]  P. Baran,et al.  Sulfhydryl-based dendritic chain reaction. , 2010, Chemical communications.

[13]  Roey J. Amir,et al.  Receiver-amplifier, self-immolative dendritic device. , 2007, Chemistry.

[14]  D. Shabat,et al.  Single-triggered AB6 self-immolative dendritic amplifiers. , 2007, Chemistry.

[15]  D. Shabat,et al.  The azaquinone-methide elimination: comparison study of 1,6- and 1,4-eliminations under physiological conditions. , 2008, Organic & biomolecular chemistry.

[16]  N. Pessah,et al.  A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger. , 2003, Angewandte Chemie.

[17]  L. A. Carpino,et al.  Reductive lactonization of strategically methylated quinone propionic acid esters and amides , 1989 .

[18]  J. Fréchet,et al.  Discovery of dendrimers and dendritic polymers: A brief historical perspective* , 2002 .

[19]  R. Satchi‐Fainaro,et al.  Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier. , 2007, Bioorganic & medicinal chemistry.

[20]  J. McGuire,et al.  Drug delivery systems employing 1,6-elimination: releasable poly(ethylene glycol) conjugates of proteins. , 2001, Bioconjugate chemistry.

[21]  H. Lode,et al.  Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2. , 2004, Journal of the American Chemical Society.

[22]  M. Wakselman,et al.  Groupements protecteurs benzyloxycarbonyles substitues alcalinolabiles , 1978 .

[23]  Elizabeth R Gillies,et al.  A cascade biodegradable polymer based on alternating cyclization and elimination reactions. , 2009, Journal of the American Chemical Society.

[24]  J. Klafter,et al.  Two-component dendritic chain reactions: experiment and theory. , 2010, Journal of the American Chemical Society.

[25]  B. Wang,et al.  A Redox-Sensitive Resin Linker for the Solid Phase Synthesis of C-Terminal Modified Peptides. , 1999, The Journal of organic chemistry.

[26]  D. Filpula,et al.  Controlled release of proteins from their poly(ethylene glycol) conjugates: drug delivery systems employing 1,6-elimination. , 2003, Bioconjugate chemistry.

[27]  V. Stella,et al.  Prodrugs and site-specific drug delivery. , 1980, Journal of medicinal chemistry.

[28]  H. W. Scheeren,et al.  Synthesis of novel paclitaxel prodrugs designed for bioreductive activation in hypoxic tumour tissue. , 2002, Bioorganic & medicinal chemistry.

[29]  P. Senter,et al.  Development of a drug-release strategy based on the reductive fragmentation of benzyl carbamate disulfides , 1990 .

[30]  Prodrug Strategies in Anticancer Chemotherapy , 2008, ChemMedChem.

[31]  H. Waldmann,et al.  Enzymatically cleavable linker groups in polymer-supported synthesis. , 2002, Drug discovery today.

[32]  H. Zhao,et al.  Drug delivery systems employing 1,4- or 1,6-elimination: poly(ethylene glycol) prodrugs of amine-containing compounds. , 1999, Journal of medicinal chemistry.

[33]  P. Baran,et al.  The pyridinone-methide elimination. , 2009, Organic & biomolecular chemistry.

[34]  J. Suggs,et al.  Facile hydrolysis and formation of amide bonds by N-hydroxyethylation of α-amino acids , 1997 .

[35]  William A. Goddard,et al.  Starburst dendrimers. 5. Molecular shape control , 1989 .

[36]  J. Katzenellenbogen,et al.  Plasmin-activated prodrugs for cancer chemotherapy. 2. Synthesis and biological activity of peptidyl derivatives of doxorubicin. , 1983, Journal of medicinal chemistry.

[37]  R. Duncan,et al.  PDEPT: polymer-directed enzyme prodrug therapy , 2001, British Journal of Cancer.

[38]  R. McCarley,et al.  Chemically and Electrochemically Mediated Release of Dendrimer End Groups , 2006 .

[39]  Angela C Cruciano,et al.  Redox-triggered contents release from liposomes. , 2008, Journal of the American Chemical Society.

[40]  S. Smith,et al.  Cyclization-activated prodrugs. Basic esters of 5-bromo-2'-deoxyuridine. , 1990, Journal of medicinal chemistry.

[41]  Yoshio Hayashi,et al.  Paclitaxel prodrugs: toward smarter delivery of anticancer agents. , 2006, Journal of medicinal chemistry.

[42]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[43]  D. Shabat,et al.  Self-immolative comb-polymers: multiple-release of side-reporters by a single stimulus event. , 2008, Chemistry.

[44]  R. Satchi‐Fainaro,et al.  Real-time monitoring of drug release. , 2010, Chemical communications.

[45]  D. Shabat,et al.  New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering. , 2004, Bioorganic & medicinal chemistry.

[46]  R. McCarley,et al.  Redox-driven shaving of dendrimers. , 2005, Chemical communications.

[47]  R. Satchi‐Fainaro,et al.  Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel. , 2009, Bioorganic & medicinal chemistry.

[48]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[49]  W. Marsden.  I and J , 2012 .

[50]  D. Shabat,et al.  Dendritic chain reaction. , 2009, Journal of the American Chemical Society.

[51]  D. McGrath,et al.  Dendrimer disassembly by benzyl ether depolymerization. , 2003, Journal of the American Chemical Society.

[52]  L. Lo,et al.  Development of highly selective and sensitive probes for hydrogen. , 2003, Chemical communications.

[53]  P. Bertrand,et al.  Click chemistry with O-dimethylpropargylcarbamate for preparation of pH-sensitive functional groups. A case study. , 2007, The Journal of organic chemistry.

[54]  J. Florent,et al.  Design of selectively activated anticancer prodrugs: elimination and cyclization strategies. , 2002, Current medicinal chemistry. Anti-cancer agents.

[55]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[56]  H. Waldmann,et al.  An enzyme-labile safety catch linker for synthesis on a soluble polymeric support. , 2001, Chemistry.

[57]  G. Ast,et al.  Bioactivation of carbamate-based 20(S)-camptothecin prodrugs. , 2004, Bioorganic & medicinal chemistry.

[58]  H. W. Scheeren,et al.  Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release. , 2001, The Journal of organic chemistry.

[59]  D. McGrath,et al.  Geometric disassembly of dendrimers: dendritic amplification. , 2003, Journal of the American Chemical Society.

[60]  J. Katzenellenbogen,et al.  A novel connector linkage applicable in prodrug design. , 1981, Journal of medicinal chemistry.

[61]  H. W. Scheeren,et al.  "Cascade-release dendrimers" liberate all end groups upon a single triggering event in the dendritic core. , 2003, Angewandte Chemie.

[62]  S. Milstien,et al.  Stereopopulation control. I. Rate enhancement in the lactonizations of 0-hydroxyhydrocinnamic acids. , 1972, Journal of the American Chemical Society.

[63]  Roey J. Amir,et al.  Substituent-dependent disassembly of self-immolative dendrimers , 2007 .

[64]  Waldmann,et al.  An Enzyme-Labile Safety Catch Linker for Combinatorial Synthesis on a Soluble Polymeric Support This work was supported by the Bundesministerium für Bildung und Forschung and BASF AG. , 2000, Angewandte Chemie.

[65]  B. F. Cain.  2-Acyloxymethylbenzoic acids. Novel amine protective functions providing amides with the lability of esters , 1976 .

[66]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[67]  W. Denny,et al.  Substituent effects on the kinetics of reductively-initiated fragmentation of nitrobenzyl carbamates designed as triggers for bioreductive prodrugs , 1999 .

[68]  Adah Almutairi,et al.  UV and near-IR triggered release from polymeric nanoparticles. , 2010, Journal of the American Chemical Society.

[69]  B. Attali,et al.  Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry. , 2006, Bioconjugate chemistry.

[70]  W. Denny,et al.  Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. , 2003, Journal of medicinal chemistry.

[71]  H. W. Scheeren,et al.  Synthesis and biological evaluation of novel prodrugs of anthracyclines for selective activation by the tumor-associated protease plasmin. , 1999, Journal of medicinal chemistry.

[72]  Roey J. Amir,et al.  Self-immolative dendrimers. , 2003, Angewandte Chemie.

[73]  Jae-Kon Choi,et al.  Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs , 2008, Journal of biomaterials science. Polymer edition.

[74]  C. Hawker,et al.  A new convergent approach to monodisperse dendritic macromolecules , 1990 .

[75]  E. Gillies,et al.  A reduction sensitive cascade biodegradable linear polymer , 2010 .

[76]  Raphael Dumeunier,et al.  Latent fluorophores based on a self-immolative linker strategy and suitable for protease sensing. , 2008, Bioconjugate chemistry.

[77]  D. Shabat.  Self‐immolative dendrimers as novel drug delivery platforms , 2006 .

[78]  Scott R White,et al.  Programmable microcapsules from self-immolative polymers. , 2010, Journal of the American Chemical Society.

[79]  L. D. Taylor,et al.  Use of o- and p-hydroxybenzyl functions as blocking groups which are removable with base , 1978 .

[80]  J. Davies,et al.  PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination. , 2003, Bioconjugate chemistry.

[81]  D. Thakker,et al.  Prodrugs of anticancer agents , 1996 .

[82]  H. Waldmann,et al.  An Enzyme-Labile Linker Group for Organic Syntheses on Solid Supports. , 1998, Angewandte Chemie.

[83]  R. Lerner,et al.  Single-triggered trimeric prodrugs. , 2005, Angewandte Chemie.

[84]  Z. Lu,et al.  Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[85]  S. Smith,et al.  Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole. , 1990, Journal of medicinal chemistry.

[86]  C. Barbas,et al.  In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[87]  D. Shabat,et al.  Self-immolative dendrimers: A distinctive approach to molecular amplification , 2010 .

[88]  F. Kratz,et al.  2,4-Bis(hydroxymethyl)aniline as a building block for oligomers with self-eliminating and multiple release properties. , 2008, The Journal of organic chemistry.

[89]  D. Shabat,et al.  Molecular probe for enzymatic activity with dual output. , 2007, Bioorganic & medicinal chemistry.

[90]  J. Fréchet,et al.  Synthesis and characterization of hyperbranched polyurethanes prepared from blocked isocyanate monomers by step-growth polymerization , 1993 .

[91]  K. Ulbrich,et al.  Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. , 1989, Biomaterials.

[92]  C. Monneret,et al.  Synthesis of novel targeted pro-prodrugs of anthracyclines potentially activated by a monoclonal antibody galactosidase conjugate (part 1) , 1992 .

[93]  Richard A Lerner,et al.  Prodrug activation gated by a molecular "OR" logic trigger. , 2005, Angewandte Chemie.

[94]  Cameron Alexander,et al.  Self-immolative polymers. , 2008, Angewandte Chemie.

[95]  Y. Quinn,et al.  New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.

[96]  D. Shabat,et al.  Enzymatic activation of hydrophobic self-immolative dendrimers: the effect of reporters with ionizable functional groups. , 2009, Bioorganic & medicinal chemistry letters.

[97]  H. W. Scheeren,et al.  Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin. , 2000, Journal of medicinal chemistry.